![]()
The Philippine Genome Center Visayas has already received its set of Next Generation Sequencers to capacitate the center for whole genome sequencing to detect SARS-CoV-2 variants in the region. PGC Visayas acquired the sequencers through the funding support of the Department of Budget and Management. Installation of the sequencers commenced last Thursday (Jan. 20) at the PGC Visayas Laboratories at the Regional Research Center of UPV in Miagao, Iloilo. Installation is set to be complete over the weekend, and the initial trial run will commence on Monday (Jan. 24). Another series of minor runs will follow this over the next two weeks to optimize all the systems in place. Full operations are targeted to start by the 3rd or 4th week of February, upon which PGC Visayas will be able to sequence around 350-375 samples per week. The sequencers acquired by PGC Visayas, the Illumina ISeq 100, and Illumina NextSeq 1000 (distributed and locally supported by Lifeline Diagnostics) are some of the latest sequencing platforms available in the market, with the installation of the NextSeq 1000 being the first in the Philippines.
